Full name
PROXIMA PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale of pharmaceutical goods
21.1 - Manufacture of basic pharmaceutical substances
21.2 - Manufacture of medicines and other pharmaceutical products
46.45.Z - Wholesale of perfume and cosmetics
70.2 - Management consultancy activities
73.1 - Advertising
82.92.Z - Packaging activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 19,8 | -28,9 | 4,6 | 116 |
EBITDA | 22,9 | -23 | 13,6 | 159 |
Short time liabilities | 258,8 | 259,9 | 246,8 | -5 |
Equity capital | -141,6 | -170,5 | -165,9 | 2,7 |
Operating profit (EBIT) | 22,9 | -24 | 9,4 | 138,9 |
Assets | 117,3 | 89,3 | 80,9 | -9,5 |
Net profit (loss) | 19,8 | -28,9 | 4,6 | 116 |
Cash | 39,7 | 35,4 | 6,7 | -81 |
Net income from sale | 461,3 | 485,4 | 462,2 | -4,8 |
Liabilities and provisions for liabilities | 258,8 | 259,9 | 246,8 | -5 |
Working assets | 117,3 | 69,4 | 65,1 | -6,2 |
Depreciation | 0 | 1,1 | 4,2 | 300 |
% | % | % | p.p. | |
Profitability of capital | -14 | 17 | -2,8 | -19,8 |
Equity capital to total assets | -120,7 | -190,8 | -205,1 | -14,3 |
Gross profit margin | 4,3 | -6 | 1 | 7 |
EBITDA Margin | 5 | -4,7 | 2,9 | 7,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 205 | 195 | 195 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane